Medpace

Approximately 56.9 million people worldwide are living with #Alzheimer’s Disease and other dementias, projected to rise to 78 million by 2030. With few approved and effective therapeutic interventions available, there is an urgent need for new treatment options to address the profound impact on patients, families, and society. Download this article to explore the challenges of AD and #neurodegenerative clinical trials, recent successes in the field, and strategies for achieving success in these trials: https://lnkd.in/gHevTguM

As Medpace's Executive Director of Clinical Packaging & Supplies, Mary Ellen Weber not only built her department from the ground up, but also established a mentorship structure to support entry-level associates. Learn more about how her #leadership shaped a vital team at Medpace in our latest #careers blog post. Check out the full Q+A: https://bit.ly/4ip1gce #WorkAtMedpace #Mentorship

The insights emerging from #ASH2024 provide a pivotal roadmap for biopharma companies aiming to stay at the forefront of #hematology innovation. From advancing therapeutic scalability to optimized clinical trial designs, the data presented offers an opportunity to refine clinical strategies, enhance patient access, and shorten development timelines. “Congratulations to the Investigators and Sponsors whose groundbreaking data at ASH 2024 is advancing hematology research. Medpace is proud to partner with biopharma to bring innovative therapies to patients in need and looks forward to driving progress in the year ahead," shares Dr. Blythe Thomson, Senior Vice President of Hematology and Oncology at Medpace. Stay ahead of the curve—explore insights designed to empower biopharma success: https://lnkd.in/gtBYtmKk

Explore career breakthroughs at Medpace! In our latest #careers blog post, Nick O'Hanlon, Clinical Research Associate, shares advice and describes how he and his team are driving the development of clinical research through collaboration. Read the the full Q+A: https://bit.ly/4ip1gce #WorkAtMedpace

In the final video of the series, Maria Beatriz (Bia) Michelini, Ph.D. and Juliana Polachini de Castro share key aspects of the Medpace infectious diseases and vaccines clinical operations team in Latin America, specializing in the design and execution of global trials for antivirals, antibacterials, antifungals, vaccines, and immunotherapies. Our infectious diseases experts have country and region-specific expertise, allowing us to seamlessly integrate local language, culture, and requirements into study conduct. Learn more about Medpace's clinical development capabilities in #InfectiousDiseases and #Vaccines: https://lnkd.in/g-Z8FfPd

Interested in breaking into the clinical research industry? Sonia Lourdes, Associate Clinical Trial Manager, shares her experience joining our Medpace Australia office in our latest #careers blog. Get insights into Sonia's journey and the training and mentorship she received. Read the the full Q+A here: https://bit.ly/4ip1gce #WorkAtMedpace #ClinicalResearch

It's #MedpaceMonday! As proud sponsors of Bearcats® Athletics, we recognize the dedication and teamwork that drive success—whether it's on the field or in clinical research. At Medpace, we support our clients in advancing the development treatments for diseases that impact millions, inspiring solutions that make our team, our communities, and our world better. Join over 570 University of Cincinnati graduates who've built their careers at Medpace. Browse open positions to consider joining our elite team today: https://bit.ly/3YiUQSK #WorkAtMedpace #StudentAthlete

Discover how Medpace fosters career breakthroughs! In our latest #careers blog, Medpace associates share their journeys, from collaboration and mentorship to training and career growth. Explore insights from Konrad Parzych, CRA Manager, on his career journey at our Poland office. Read the the full Q+A here: https://bit.ly/4ip1gce #WorkAtMedpace #CareerGrowth #LifeAtMedpace

Imaging techniques play a crucial role in cardiovascular research by enabling the visualization and quantification of the structure and function of the heart and blood vessels. Each imaging method offers unique benefits and limitaitons. This whitepaper delves into the value of #imaging #endpoints in #cardiovascular studies, highlighting their role in refining therapeutic approaches and enhancing the predictability and success of clinical outcomes. Download the whitepaper today to explore multimodality imaging in cardiovascular clinical trials: https://lnkd.in/daZnKfWr

Breakthroughs in precison medicine, scalable allogeneic CAR-T therapies, and next-generation trial designs are redefining #hematology. These advancements are creating new possibilities in clinical trials, equipping biopharma with the tools to drive innovation and improve patient outcomes. In our latest newsletter, Dr. Blythe Thomson, Senior Vice President of Hematology and Oncology, highlights 10 advancements poised to shape conversations at #ASH2024. Discover how Medpace partners with biopharma to translate groundbreaking science into clinical and regulatory success—schedule a meeting with Dr. Thomson and our on-site experts today: https://lnkd.in/gEeRk9Cf